GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,494,000 | +12.9% | 103,218 | +12.9% | 0.04% | +33.3% |
| Q1 2022 | $3,981,000 | -6.6% | 91,400 | -5.4% | 0.03% | -6.2% |
| Q4 2021 | $4,261,000 | -10.6% | 96,620 | -22.5% | 0.03% | +6.7% |
| Q3 2021 | $4,764,000 | +56.7% | 124,704 | +63.3% | 0.03% | +11.1% |
| Q2 2021 | $3,041,000 | +6.2% | 76,363 | -4.8% | 0.03% | 0.0% |
| Q1 2021 | $2,864,000 | -5.3% | 80,255 | -2.3% | 0.03% | -15.6% |
| Q4 2020 | $3,023,000 | +22.1% | 82,135 | +29.4% | 0.03% | 0.0% |
| Q3 2020 | $2,475,000 | -5.5% | 63,451 | -1.2% | 0.03% | -11.1% |
| Q2 2020 | $2,618,000 | +11.6% | 64,192 | +3.7% | 0.04% | -16.3% |
| Q1 2020 | $2,346,000 | -30.9% | 61,901 | -14.3% | 0.04% | -18.9% |
| Q4 2019 | $3,395,000 | -4.0% | 72,251 | -10.8% | 0.05% | -3.6% |
| Q3 2019 | $3,536,000 | -33.5% | 81,017 | -40.4% | 0.06% | -42.7% |
| Q2 2019 | $5,314,000 | +106.0% | 135,966 | +120.2% | 0.10% | +88.2% |
| Q1 2019 | $2,580,000 | +25.5% | 61,757 | +14.8% | 0.05% | +2.0% |
| Q4 2018 | $2,055,000 | -21.3% | 53,773 | -17.3% | 0.05% | -7.4% |
| Q3 2018 | $2,612,000 | -2.6% | 65,026 | -2.6% | 0.05% | +22.7% |
| Q2 2018 | $2,681,000 | +129.7% | 66,742 | +123.4% | 0.04% | -4.3% |
| Q1 2018 | $1,167,000 | -32.9% | 29,874 | -36.2% | 0.05% | -37.0% |
| Q4 2017 | $1,739,000 | -45.1% | 46,857 | -39.9% | 0.07% | -6.4% |
| Q3 2017 | $3,166,000 | +3.1% | 77,976 | +7.2% | 0.08% | -6.0% |
| Q2 2017 | $3,072,000 | +2.1% | 72,764 | +1.5% | 0.08% | -1.2% |
| Q1 2017 | $3,008,000 | +22.3% | 71,709 | +13.8% | 0.08% | +3.7% |
| Q4 2016 | $2,460,000 | +6.2% | 63,006 | +18.1% | 0.08% | -13.8% |
| Q3 2016 | $2,316,000 | -15.5% | 53,342 | -15.0% | 0.09% | -15.3% |
| Q2 2016 | $2,740,000 | +48.8% | 62,787 | +39.4% | 0.11% | +24.7% |
| Q1 2016 | $1,842,000 | -34.3% | 45,035 | -35.1% | 0.09% | -33.6% |
| Q4 2015 | $2,802,000 | +11.5% | 69,439 | +6.2% | 0.13% | -2.9% |
| Q3 2015 | $2,514,000 | +7.6% | 65,383 | +16.6% | 0.14% | +24.3% |
| Q2 2015 | $2,336,000 | +2.1% | 56,057 | +13.0% | 0.11% | -15.9% |
| Q1 2015 | $2,289,000 | +29.5% | 49,591 | +20.0% | 0.13% | +15.8% |
| Q4 2014 | $1,767,000 | -1.3% | 41,334 | +6.1% | 0.11% | -8.1% |
| Q3 2014 | $1,791,000 | +6.3% | 38,956 | +23.6% | 0.12% | -14.5% |
| Q2 2014 | $1,685,000 | +4.8% | 31,514 | +4.7% | 0.14% | -14.2% |
| Q1 2014 | $1,608,000 | +6.0% | 30,102 | +6.0% | 0.17% | 0.0% |
| Q4 2013 | $1,517,000 | – | 28,405 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |